The largest database of trusted experimental protocols

Pvuii hf

Manufactured by New England Biolabs

PvuII-HF is a type II restriction endonuclease enzyme produced by New England Biolabs. It recognizes and cleaves the DNA sequence 5'-CAG↓CTG-3' and its reverse complement. PvuII-HF can be used for various molecular biology applications, such as DNA digestion and mapping.

Automatically generated - may contain errors

3 protocols using pvuii hf

1

Muscle DNA Restriction and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total DNA from muscle (300 ng) as above was restricted using 10 U of BamHI‐HF or PvuII‐HF (NEB) as indicated for 1 h at 37°C. For experiments including T7 endonuclease I, 250 ng of muscle DNA was restricted using 10 U of BamHI for 30 min at 37°C, then 1 U of T7 endonuclease I (NEB) was added and the reactions were incubated for a further 30 min at 37°C. Reactions were separated on 0.6% agarose gels for 4 h at 110 V. Gels were incubated in depurination buffer (0.25 M HCl) for 20 min, followed by denaturation buffer (0.5 M NaOH, 1.5 M NaCl) for 2 × 10 min and then neutralisation buffer (0.5 M tris–HCl (pH 7.4), 1.5 M NaCl) for a further 2 × 10 min. Gels were blotted onto nylon membrane (Hybond‐N+, Amersham) overnight and then crosslinked using UV at 1200 mJ/cm2. A probe (corresponding to mtDNA loci nt. 16262‐128) was synthesised by radiolabelling a PCR product using a Prime‐It II random primer labelling kit (Agilent); see Appendix Table S1 for primer sequences. Membranes were hybridised overnight at 60°C in hybridisation buffer (0.25 M phosphate buffer, 7% (w/v) SDS), then washed for 3 × 20 min with 1 × SSC containing 0.1% (w/v) SDS and imaged using a Typhoon FLA 9500 or exposed to X‐ray film.
+ Open protocol
+ Expand
2

Engineering Escape Mutant Hemagglutinin Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, the H mutant (H82) was generated by engineering escape mutations
in the Hemagglutin (H) gene (Accession AB583749) encoded in the pCG plasmid
(pCG-H). Mutations in H82 are as follows: L284S, E395K, E398G, E535N, H536A,
A537T, Y310C, D416N, S546N, R547A, S550T, F552N, Y553G, P554T, S590N, G592S.
Mutations were added sequentially by site-directed mutagenesis using the
QuikChange® Lightning Site-Directed Mutagenesis Kit (Agilent
Technologies) as per manufacture’s directions. The
IEGR-AAQPA-EGFR.scFv-AAA-RGSHHHHHH C-terminal linker and EGFR.scFv domain, was
added to H82 by digesting pCG-H82 and pTN-H6-Haa-αEGFR [29 (link)] with Pac1 and PvuII-HF (New
England biolabs). The H fragment from pCG-H82 replaced the H fragment in
pTN-H6-Haa-αEGFR to generate pTN-H82-αEGFR.
P+MV-H82.αEGFR was then generated by replacing the H gene in
p+MV-eGFP, with H82.αEGFR by digesting p+MVeGFP and
pTN-H82-αEGFR with restriction enzymes Pac1 and Spe1 (New England
biolabs).
+ Open protocol
+ Expand
3

Evaluating Restriction Enzyme Efficiency

Check if the same lab product or an alternative is used in the 5 most similar protocols
To gauge the efficiency of the restriction enzymes (REs), 20 fmol (580 ng) of two complementary ssODNs designed to contain restriction sites for both enzymes (‘ssODN_REs_ctrl’ and ‘ssODN_REs_ctrl _rc’ in Supplementary Data 8) were annealed in NEB2 buffer (1×) in a final volume of 12 µL by denaturing at 98 °C for 5 min, then cooled at 0.1 °C/s to 20 °C (‘ssODN_REs_ctrl’ and ‘ssODN_REs_ctrl_rc’ in Supplementary Data 8). Then, 200 ng (2 µL) of annealed ssODNs was digested with either BfaI or PvuII-HF (1 U, New England Biolabs) in CutSmart buffer (1×) in a total volume of 10 µL and incubated at 37 °C for 1 h. Immediately after digestion, reactions were separated on an agarose gel (1.5%) stained with SYBR Safe (1×), imaged (UVP BioDoc-It) and analysed semi-quantitatively by gel densitometry using ImageJ (Supplementary Data 14).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!